LyondellBasell updates potential plans for Houston refinery site

LyondellBasell updates potential plans for Houston refinery site

MRC -- LyondellBasell Industries Holdings BV is proceeding with a potential plan to transition subsidiary Houston Refining LP's (HRL) soon-to-be-shuttered 268,000-b/d Houston full-conversion refinery into a hydrogen production site as part of the proposed US government-funded HyVelocity regional hydrogen hub, said the company.

Confirmation of LyondellBasell's possible participation in HyVelocity follows $1.2 bn of $7 bn in federal grants awarded by US President Biden's administration in mid-Oct 2023 to the project, which is sponsored by ExxonMobil Corp, Chevron Corp, Air Liquide SA, Mitsubishi Power Americas, AES Corp, Sempra Infrastructure, and Oersted AS. As development of the Houston refinery-to-hydrogen site remains ongoing, Vanacker said the company will continue to evaluate other projects in line with its circular and low-carbon solutions business involving reuse of the refinery's existing hydrotreaters, including: Using LyondellBasell's proprietary MoReTec advanced recycling technology to upgrade and purify mixed plastic waste into pyrolysis oil that can be used as feedstock for new plastic materials. Using MoReTec advanced recycling technology to upgrade and purify mixed plastic waste into pyrolysis gas that can be shipped via existing pipeline connections from the refinery to LyondellBasell's nearby olefins manufacturing complex in Channelview, TX, for use as feedstock in that site's steam crackers.

Revamping the refinery's existing hydrotreaters to process renewable-based feedstocks for production of renewable hydrocarbons that also could be transported to Channelview, TX, for use as feedstock to the site's steam crackers. With dedicated teams currently analyzing the various potential projects for the future use of the refinery, the company will proceed with normal routes for FID once those studies are completed, according to Vanacker. Previously slated for closure by end-2023, LyondellBasell said in May 2023 that it would delay ceasing operations at the Houston refinery until 'no later' than end-1Q 2025.

We remind, LyondellBasell Industries announced net income for the third quarter 2023 of $0.7 billion, or $2.29 per diluted share, said the company. During the quarter, the company recognized identified items of $57 million, net of tax, which impacted third quarter earnings by $0.17 per share. Third quarter 2023 EBITDA was $1.4 billion.

mrchub.com

Henkel introduces new medical grade wearables device light cure adhesives

Henkel introduces new medical grade wearables device light cure adhesives

MRC -- Henkel has launched a novel medical grade light cure adhesive designed for devices that are to be worn on the body, said the company.

The new product is formulated without IBOA (Isobornyl Acrylate) or any other known skin sensitizing monomers. The adhesive is also formulated to conform to EU MDR 2017 regulations concerning use of CMR (carcinogenic, mutagenic, or toxic for reproduction) substances in medical devices making it a robust option for new designs.

The newly developed adhesive is available in two different grades. Loctite WT 3001 and Loctite WT 3003 have both been tested according to ISO 10993 standards, ensuring a high level of safety and performance for users. The solutions have also been tested for skin sensitization, making them suitable for a wide range of medical applications including wearable devices.

With the increasing demand for medical devices and wearables, the need for safe and reliable adhesive solutions has never been more crucial. Henkel's new wearable device light cure adhesive provides an excellent bonding solution for medical devices, ensuring strong and durable connections while remaining free of known skin sensitizing monomers such as Isobornyl Acrylate (IBOA). IBOA is known in that medical community for causing patient skin reactions when used in wearables.

”At Henkel, we are committed to providing our customers with innovative adhesive solutions that meet the highest safety standards,” said Philipp Loosen, Vice President and Head of Industrials EIMEA and Global Key Accounts Medical at Henkel. ”With the introduction of our new medical grade wearable device light cure adhesive, we are addressing the growing need for safe and effective adhesives in the medical industry. Our adhesive is ISO 10993 tested and formulated with patient comfort and safety in mind, ensuring its suitability for use in medical device bonding and medical wearables.”

Henkel's wearable device light cure adhesive offers various benefits for medical applications. Its light cure capabilities allow for quick and efficient bonding, reducing production time and increasing productivity. The adhesive also provides excellent adhesion to a wide range of substrates commonly used in medical devices and wearables, ensuring robust bonding and sealing performance after drop impact or bathing.

Furthermore, the adhesive's formulation meets FDA & EU MDR recommendations for wearable medical devices regarding sensitizing and CMR ingredients. Henkel is committed to meeting regulatory requirements and delivering safe and reliable adhesive solutions to its customers. The focus on removing all known skin sensitizing monomers further reduces the risk of skin sensitization making the adhesive suitable for prolonged skin contact in medical applications.

With the trend of the integrated and connected devices, medical wearables look to incorporate advanced technologies and data-driven approaches into the healthcare industry. Henkel offers a broad material solutions portfolio for medical wearables, including low-pressure molding technologies, skin bonding, assembly adhesives, circuit board protection, and printable conductive/functional inks for biosensors.

We remind, Henkel acquired the US-based Critica Infrastructure (“Critica”), a specialized supplier of maintenance, repair and overhaul (MRO) composite solutions for the world’s most critical infrastructure such as oil and gas transmission as well as municipal water supply systems. Critica is active in many countries with a strong focus on North America and is expected to reach sales of around 100 million euros (around 110 million USD) in 2023.

mrchub.com

Braskem and Oxiteno sign a partnership to supply bio-attributed ethylene

Braskem and Oxiteno sign a partnership to supply bio-attributed ethylene

MRC -- Brazilian petrochemical companies Braskem and Indorama Ventures IOD - Oxiteno announce a partnership to supply bio-attributed ethylene from renewable sources, said the company.

Bio-attributed ethylene, certified by ISCC (International Sustainability and Carbon Certification), will be used by Oxiteno to create new sustainable solutions.

This raw material is the first bio-attributed chemical product produced by Braskem from the certified mass balance approach. The concept co-processes traditional carbon sources with recycled or renewable components to develop chemical solutions with a sustainability attribute, maintaining properties and quality compared to conventional solutions. Furthermore, it contributes to reducing the use of fossil raw materials and greenhouse gas emissions.

“Braskem and Oxiteno have aligned sustainability initiatives and this partnership is of great importance for the growth strategy of both, being one more step for the industry towards a sustainable future. The initiative should define new paths for sustainability in our petrochemical sector”, Marlisa Reche explains, Chemicals - Olefins and Aromatics Business Director at Braskem.

“There is a significant connection between our innovation strategy and our sustainability objectives. This initiative aligns with our main guidelines of decarbonization and promoting eco-efficiency in our operations. This partnership further underscores our company's mission to 'Reimagine Chemistry Together to Create a Better World,' enabling us to develop innovative and sustainable products while ensuring our organization is prepared for the future”, explains Andrea Campos Soares, Sr VP Business, Marketing & Innovation at Oxiteno.

We remind, Braskem, the leading global biopolymer producer, announced the opening of its Representative Office in Tokyo, Japan one of the key markets for Braskem's I'm greenT bio-based Polyethylene (PE), said the company.
This expansion reinforces our continuous commitment to the Japanese market and the continued development the biopolymer solutions based on renewable feedstock.

mrchub.com

Henkel acquires supplier of MRO composite solutions in US

Henkel acquires supplier of MRO composite solutions in US

MRC -- Henkel acquired the US-based Critica Infrastructure (“Critica”), a specialized supplier of maintenance, repair and overhaul (MRO) composite solutions for the world’s most critical infrastructure such as oil and gas transmission as well as municipal water supply systems, said the company.

Critica is active in many countries with a strong focus on North America and is expected to reach sales of around 100 million euros (around 110 million USD) in 2023.

With aging infrastructure and the increasing relevance of sustainability, demand for repair solutions that extend asset life is gaining importance. Therefore, maintenance and repair solutions for industrial and municipal applications are becoming increasingly significant. While Henkel has been expanding its portfolio for maintenance, repair and overhaul (MRO) solutions over the past years, the acquisition of this attractive adjacent business adds a large, innovative and certified portfolio of composite repair and reinforcement products for the industrial and municipal infrastructure market.

“As part of our strategic growth agenda, compelling acquisitions play a key role in actively shaping our portfolio. This transaction is an important step to significantly strengthen our maintenance, repair and overhaul portfolio in a dynamically growing market by expanding our offering through innovative solutions in adjacent application areas. Our aim is to create a new platform that will enable us to add further adjacent businesses, stimulate further growth and enhance our position as global leader in the adhesive technologies market,” said Henkel CEO Carsten Knobel.

In fiscal 2023, the acquired business is expected to report sales of around 100 million euros (around 110 million USD). The company employs around 250 people and has eight production sites, most of them in the US. The business supplies products to about 3,000 asset owners, contractors, and distributors. The portfolio comprises composite wrap and reinforcement solutions as well as insertion valves for oil and gas transmission, refining, chemical, and water supply systems. The solutions are marketed under the brands CSNRI®, Advanced Valve Technologies®, Fyfe FRP and GeoTree Solutions.

“We are excited about the opportunity to add this strong innovative portfolio of fast-growing and highly profitable MRO solutions to our Adhesive Technologies business. It is a strong strategic fit to our existing portfolio, adding highly complementary repair solutions, which clearly contribute to shaping the sustainability megatrend. The transaction will enable us to create a growth platform for our MRO business, giving us access to leading maintenance service providers and contractors as well as pioneering and certified technologies for critical infrastructure,” said Mark Dorn, Executive Vice President and responsible for Henkel’s Adhesive Technologies business.

We remind, Henkel introduces new medical grade wearables device light cure adhesives. As a leading manufacturer of advanced adhesive solutions for the medical industry, Henkel has launched a novel medical grade light cure adhesive designed for devices that are to be worn on the body. The new product is formulated without IBOA (Isobornyl Acrylate) or any other known skin sensitizing monomers. The adhesive is also formulated to conform to EU MDR 2017 regulations concerning use of CMR (carcinogenic, mutagenic, or toxic for reproduction) substances in medical devices making it a robust option for new designs.

mrchub.com

Dow and Evonik announce startup of hydrogen peroxide to propylene glycol pilot plant

Dow and Evonik announce startup of hydrogen peroxide to propylene glycol pilot plant

MRC -- Dow and Evonik are proud to announce the successful start-up and operation of a pioneering hydrogen peroxide to propylene glycol (HPPG) pilot plant at Evonik’s site in Hanau, Germany, said Chemeurope.

Collaboratively developed by Dow and Evonik, the plant uses the distinct HYPROSYN® method to enable the direct synthesis of propylene glycol (PG) from hydrogen peroxide and propylene.

“At Dow, we believe in collaborating with our customers and other stakeholders to create, innovate and find solutions to big challenges. So, I am delighted to see this plant become operational through this collaboration,” said Andrew Jones, global business director for Chlor-Alkali Vinyl & Propylene Oxide, Propylene Glycol, at Dow. “With this innovative technology and flexible asset and business model, we are well positioned to meet our customers’ needs and growing market demand.”

“At Evonik Active Oxygens, we put sustainability at the core of futurizing our business. This relies not only on innovative technologies, but also the ability to scale these up and bring them to market,” remarked Michael Traxler, head of Evonik’s Active Oxygens business line. “That’s where excellent strategic partnerships come into play. The startup of this pilot plant in Hanau thus not only represents a major technological milestone in our efforts to make industry more sustainable, it is also a prime example of how cross-company collaboration, like this partnership with Dow, is essential to driving sustainable solutions.”

The pilot plant will demonstrate the benefits of the novel technology. In contrast to the traditional process, where propylene is used to make propylene oxide (PO), which is converted to PG through hydrolysis, the HYPROSYN® process uses a novel catalytic system to generate PG directly from propylene and hydrogen peroxide. The integration of all key reaction stages in a single reactor eliminates the need for additional investments in PO capacity and lowers capital requirements. The process also enables a reduced environmental footprint, e.g., water consumption is reduced to less than 5% compared to conventional PG methods. In addition, existing PG plants can be retrofitted to benefit from this new technology.

Propylene glycol serves as an essential ingredient such as a high-performing additive, intermediate, or initiator in a wide range of applications — including industrial, food and animal feed, pharmaceuticals, and cosmetics. Over the next few years, the Dow and Evonik teams will continuously evaluate the plant’s operations and capabilities to scale up manufacturing, in support of growing market demand.

We remind, Evonik has signed an agreement to develop, scale up and produce proprietary fixed bed catalysts for mobile applications of Hydrogenious LOHC Technologies’ proprietary liquid organic hydrogen carrier technology based on benzyl toluene.

mrchub.com